Explore scientific data around our next generation products. Use the filters below to narrow things down, or simply search via keyword.
Evaluation of high nicotine oral products shows potential to reduce tobacco related harm by offering satisfying alternatives
ViewA Toxicological Risk Assessment Strategy for the Responsible Development of NGP EUROTOX 2025
ViewTobacco-Free Nicotine Pouches Nicotine Release Profile can be Used to Estimate User Exposure A Comparative Analysis of In Vitro Dissolution and In Vivo Pharmacokinetics
ViewAssessment of a range of NGP using ToxTracker® and ToxProfilerTM MAX assays reveal marked reductions in biological activity compared to a cigarette EUROTOX 2025
ViewOrgan-on-a-chip modelling of early atherosclerosis events reveals reduced activity of e-vapour products compared to cigarettes
ViewAssessment of innovative Next Generation nicotine delivery products using ToxTracker
ViewAssessment of the Cardiovascular impact of e-vapour and heated tobacco products using New Approach Methodologies
ViewChemical characterisation of a ceramic wick e-vapour product aerosol reveals marked reductions in toxicant levels when compared to cigarette smoke CORESTA 2024
ViewFactors of initiation to vaping products among smokers
ViewToxicological assessment of a range of next generation product aerosols reveals marked reductions in biological activity CORESTA 2024
View
